Extra-renal Complications of ADPKD

ADPKD is a genetic disorder that causes the development of cysts in the kidneys. However, it can also lead to the formation of cysts in other organs, resulting in various extra-renal complications.

Hepatic cysts are the most common extra-renal complication, occurring in 80% of patients. While they are more prevalent in women, they are also common in men. Most cases of polycystic liver disease are asymptomatic, but symptoms can arise from the mass effect or complications of the cyst.

Seminal vesicle cysts are also common in patients with ADPKD, but they rarely result in male infertility. On the other hand, cerebral aneurysms occur in 10-20% of patients and can cause cranial nerve palsies or seizures. They are not as common as hepatic cysts.

Pancreatitis is a rare complication that can develop if cysts grow large enough to impact the pancreas. Fortunately, it is unlikely to occur in most patients.

Mitral valve prolapse and aortic incompetence are also associated with ADPKD. Mitral valve prolapse occurs in 25% of patients, making it a common occurrence but not the most likely extra-renal complication that this patient is likely to develop.

In summary, ADPKD can lead to various extra-renal complications, but hepatic cysts and cerebral aneurysms are the most common. Regular monitoring and management of these complications are essential to ensure the best possible outcomes for patients.

Prostate Cancer Screening and Testing: Important Considerations

In patients with lower urinary tract symptoms (LUTS), it is important to consider the possibility of locally advanced prostate cancer causing obstructive LUTS. Therefore, a prostate-specific antigen (PSA) test and digital rectal exam (DRE) should be offered to men with obstructive symptoms.

While family history is a significant risk factor for prostate cancer, a grandfather’s history of the disease may not be as significant as a first-degree relative’s (father or brother) history.

If a man presents with symptoms of urinary tract infection, it is important to investigate and treat the infection before considering any PSA testing. Prostate cancer typically doesn’t cause symptoms of urinary tract infection.

Currently, there is no formal screening program for prostate cancer. However, men may choose to request a PSA test after being informed of the potential benefits and risks. It is important to note that DRE alone should not be used for screening.

Prior to testing for PSA, it is recommended to perform DRE at least a week prior as it can falsely elevate PSA levels.

Key Considerations for Prostate Cancer Screening and Testing

Treatment options for Urinary Urge Incontinence

Urinary urge incontinence is a common condition that can be treated with supervised bladder training for at least six weeks. This training can be provided by a continence nurse, physiotherapist, or urology clinic. If symptoms persist, an Antimuscarinic drug can be prescribed, with the lowest effective dose used and titrated upwards if necessary. It may take up to four weeks for the drug to take effect, and side effects such as dry mouth and constipation may occur. First-line drugs include oxybutynin, tolterodine, and darifenacin.

It is important to note that diuretics such as furosemide can potentially worsen symptoms of urinary urge incontinence. Amitriptyline is not recommended for this condition, as it is primarily used for depression, neuropathic pain, and migraine prophylaxis. Duloxetine may be used as a second-line treatment for stress incontinence, but it is not included in NICE guidelines for urinary urge incontinence. Desmopressin is typically used for other conditions such as diabetes insipidus, multiple sclerosis, enuresis, and bleeding disorders.

In summary, supervised bladder training and Antimuscarinic drugs are effective treatment options for urinary urge incontinence. It is important to consult with a healthcare professional to determine the best course of treatment for individual cases.

The first-line investigation for suspected prostate cancer has been replaced by multiparametric MRI, replacing TRUS biopsy. This change was made in the 2019 NICE guidelines for investigating suspected prostate cancer in secondary care.

Investigation for Prostate Cancer

Prostate cancer is a common type of cancer that affects men. The traditional investigation for suspected prostate cancer was a transrectal ultrasound-guided (TRUS) biopsy. However, recent guidelines from NICE have now recommended the increasing use of multiparametric MRI as a first-line investigation. This is because TRUS biopsy can lead to complications such as sepsis, pain, fever, haematuria, and rectal bleeding.

Multiparametric MRI is now the first-line investigation for people with suspected clinically localised prostate cancer. The results are reported using a 5-point Likert scale. If the Likert scale is 3 or higher, a multiparametric MRI-influenced prostate biopsy is offered. If the Likert scale is 1-2, then NICE recommends discussing with the patient the pros and cons of having a biopsy. This approach helps to reduce the risk of complications associated with TRUS biopsy and ensures that patients receive the most appropriate investigation for their condition.

An ultrasound is the recommended first-line investigation for a testicular mass. It is important to note that a new hydrocele could be a sign of testicular malignancy, especially in males aged 20-40 years old who are at the highest risk. Therefore, NICE guidelines state that urgent scrotal ultrasound is necessary for investigating new hydroceles in this age group. It is not appropriate to simply reassure the patient or request a routine ultrasound or outpatient review, as this could delay the diagnosis of malignancy. Blood tests to check for tumour markers may be appropriate after the identification of suspected testicular malignancy.

Testicular cancer is a common type of cancer that affects men between the ages of 20 and 30. The majority of cases (95%) are germ-cell tumors, which can be further classified as seminomas or non-seminomas. Non-germ cell tumors, such as Leydig cell tumors and sarcomas, are less common. Risk factors for testicular cancer include infertility, cryptorchidism, family history, Klinefelter’s syndrome, and mumps orchitis. Symptoms may include a painless lump, pain, hydrocele, and gynaecomastia.

Tumour markers can be used to diagnose testicular cancer. For germ cell tumors, hCG may be elevated in seminomas, while AFP and/or beta-hCG are elevated in non-seminomas. LDH may also be elevated in germ cell tumors. Ultrasound is the first-line diagnostic tool.

Treatment for testicular cancer depends on the type and stage of the tumor. Orchidectomy, chemotherapy, and radiotherapy may be used. Prognosis is generally excellent, with a 5-year survival rate of around 95% for Stage I seminomas and 85% for Stage I teratomas.

If a patient experiences an increase in serum creatinine after starting an ACE-inhibitor like ramipril, it may indicate renal artery stenosis. Other signs of this condition include refractory hypertension and recurrent pulmonary edema with normal left ventricular function. A normal urine dip makes options 1, 2, and 3 unlikely, and there are no symptoms of cancer, infection, or diabetes. While polycystic kidney disease is a possibility, it is inherited in an autosomal dominant manner and typically presents with hypertension, kidney stones, haematuria, or an abdominal mass. However, given the patient’s history and lack of family history of renal disease, renal artery stenosis is the more likely diagnosis.

Chronic kidney disease (CKD) is a condition where the kidneys are not functioning properly. To estimate renal function, serum creatinine levels are often used, but this may not be accurate due to differences in muscle. Therefore, formulas such as the Modification of Diet in Renal Disease (MDRD) equation are used to estimate the glomerular filtration rate (eGFR). The MDRD equation takes into account serum creatinine, age, gender, and ethnicity. However, factors such as pregnancy, muscle mass, and recent red meat consumption may affect the accuracy of the result.

CKD can be classified based on the eGFR. Stage 1 CKD is when the eGFR is greater than 90 ml/min, but there are signs of kidney damage on other tests. If all kidney tests are normal, there is no CKD. Stage 2 CKD is when the eGFR is between 60-90 ml/min with some sign of kidney damage. Stage 3a and 3b CKD are when the eGFR is between 45-59 ml/min and 30-44 ml/min, respectively, indicating a moderate reduction in kidney function. Stage 4 CKD is when the eGFR is between 15-29 ml/min, indicating a severe reduction in kidney function. Stage 5 CKD is when the eGFR is less than 15 ml/min, indicating established kidney failure, and dialysis or a kidney transplant may be necessary. It is important to note that normal U&Es and no proteinuria are required for a diagnosis of CKD.

Understanding Haematospermia: Causes and Symptoms

Haematospermia, the presence of blood in the ejaculate, is a common and usually benign symptom that can affect men of any age. In about 50% of cases, the cause is unknown and the symptom is self-limiting. However, further investigation may be necessary for men over 40 or those with accompanying symptoms such as perineal pain or abnormal examination findings.

Other conditions, such as urinary tract infections, epididymitis, hypertension, and prostate cancer, can also cause haematospermia. However, these conditions are usually accompanied by other symptoms such as dysuria, testicular pain, urinary symptoms, penile discharge, headaches, visual disturbance, or are unlikely in a 35-year-old man without any other symptoms.

It is important to seek medical attention if haematospermia persists or is accompanied by other symptoms.

PSA Testing for Prostate Cancer

Prostate specific antigen (PSA) is an enzyme produced by the prostate gland, and it is used as a tumour marker for prostate cancer. However, there is still much debate about its usefulness as a screening tool. The NHS Prostate Cancer Risk Management Programme (PCRMP) has published guidelines on how to handle requests for PSA testing in asymptomatic men. The National Screening Committee has decided not to introduce a prostate cancer screening programme yet, but rather allow men to make an informed choice.

The PCRMP has recommended age-adjusted upper limits for PSA, while NICE Clinical Knowledge Summaries suggest a lower threshold for referral. However, PSA levels may also be raised by other conditions such as benign prostatic hyperplasia, prostatitis, urinary tract infection, ejaculation, vigorous exercise, urinary retention, and instrumentation of the urinary tract.

PSA testing has poor specificity and sensitivity, and various methods are used to try and add greater meaning to a PSA level, including age-adjusted upper limits and monitoring change in PSA level with time. It is important to note that digital rectal examination may or may not cause a rise in PSA levels, which is a matter of debate.

Renal Failure and its Effects on Electrolyte Balance

Renal failure can lead to metabolic acidosis due to decreased excretion of H+ ions and reduced synthesis of urinary buffers such as phosphate and ammonia. This results in a marked decrease in urinary phosphate levels and a rise in extracellular potassium levels due to intracellular displacement. Calcium homeostasis is also affected as the kidney’s role in activating vitamin D and increasing calcium reabsorption from the kidneys is inhibited by phosphate retention. Sodium levels may be normal or decreased due to water retention outweighing the decreased excretion. Overall, renal failure has significant effects on electrolyte balance.

Diagnosing Nephrotic Syndrome: The Importance of Proteinuria and Renal Biopsy

Nephrotic syndrome is characterized by proteinuria (>3g/24 hours), hypoalbuminaemia (<30g/l), and oedema. To quantify proteinuria, a urine ACR or PCR or 24-hour urine collection is required. However, heavy proteinuria on urine dipstick is sufficient to confirm the need for a renal biopsy. Before a renal biopsy, a renal ultrasound is necessary to ensure the presence of two kidneys and confirm kidney size and position. Autoantibodies aid in diagnosis, but the initial confirmatory investigation is the dipstick. In children and young adults, minimal change glomerulonephritis is the most likely renal biopsy finding, which may be steroid responsive and has a good prognosis.